Biotech Values

[xrymd]

I showed the NYT article this morning to an oncologist I greatly respect. He say he rarely uses it not because of money but there are better drugs namely rituxin. If someone failed first and second line theray he would consider it. if I understood him correctly bexxar and zevalin is best used for follicular cell lymphoma which is fairly rare.

It is interesting to me, how the general lay public on this board jump to all sorts of interesting conclusions. But that is what sells newspapers. I guess righteous indignation must somehow make people feel good.